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Synaptotagmins (syts) are abundant, evolutionarily conserved integral membrane proteins
that play essential roles in regulated exocytosis in nervous and endocrine systems. There
are at least 17 syt isoforms in mammals, all with tandem C-terminal C2 domains with highly
variable capacities for Ca2+ binding. Many syts play roles in neurotransmitter release or
hormone secretion or both, and a growing body of work supports a role for some syts as
Ca2+ sensors of exocytosis. Work in many types of endocrine cells has documented the
presence of a number of syt isoforms on dense-core vesicles containing various hormones.
Syts can influence the kinetics of exocytotic fusion pores and the choice of release mode
between kiss-and-run and full-fusion.Vesicles harboring different syt isoforms can preferen-
tially undergo distinct modes of exocytosis with different forms of stimulation.The diverse
properties of syt isoforms enable these proteins to shape Ca2+ sensing in endocrine cells,
thus contributing to the regulation of hormone release and the organization of complex
endocrine functions.
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INTRODUCTION
Nature employs the same basic molecular machinery for the
release of both hormones and neurotransmitters (1–4). Several
protein families function broadly in regulated exocytosis, includ-
ing SNAREs, synaptotagmins (syts), and complexins (5–7). The
rich molecular diversity within these families provides a plat-
form for variations in the release process, enabling different cell
types to tune and tailor release by blending the different molec-
ular variants of the fusion apparatus. In this way endocrine cells
can optimize secretory responses elicited by widely varying sig-
nals that are unique to each system. The rates of hormone release
from different cell types vary by over two orders of magnitude
(8). Endocrine cells secrete an extraordinary variety of hormones
by exocytosis from dense-core vesicles (DCVs), and DCVs usually
co-package collections of molecules ranging in size from small
catecholamines to large peptides (9, 10). The nature of the stim-
ulus can determine which packaged molecules will be released
(11, 12), and a single DCV can release both catecholamines and
neuropeptides simultaneously (13). Cells also can sort different
hormones to different DCVs (14, 15). The diverse forms of stor-
age and release raise questions as to how the exocytotic machinery
can be called upon to modulate release rates and enable different
types of Ca2+ signals to trigger the release of different substances
from the same cell or even the same vesicle. One can hope to gain
a better understanding of these problems by studying functional
variations within the diverse families of exocytotic proteins.
Exocytosis proceeds through a sequence of distinct steps.
Release can start once a fusion pore has formed to create a
continuous fluid pathway from the vesicle interior to the extra-
cellular space. The fusion pore is initially very small and can allow
only small molecules such as norepinephrine to pass, but after
it expands larger molecules such as chromogranins, insulin, and
glucagon can escape. It is well established that DCVs of endocrine
cells undergo two modes of exocytosis, kiss-and-run, and full-
fusion (16–19). In kiss-and-run the pore opens transiently, and
closes so that vesicles maintain their integrity as they retreat from
the plasma membrane. The fusion pore formed during kiss-and-
run can act as a filter to expel small molecules and retain larger
molecules. The small molecules can be rapidly restored by vesicu-
lar transporters so DCVs can recycle. By contrast, in full-fusion the
pore expands and the vesicle membrane collapses into the plasma
membrane. After full-fusion a DCV is lost; replacing these DCVs
requires the entire production sequence beginning with peptide
hormone translation in the endoplasmic reticulum, DCV process-
ing in the trans-Golgi network, and maturation (20). The choice
between full-fusion and kiss-and-run thus plays a decisive role
in determining the fate of the DCV as well as in selecting what
molecules are released.
Ca2+ triggers exocytosis by binding to syt (21–23), but Ca2+
can also influence the kinetics of fusion pores in a variety of ways
(24–26), thus raising the possibility that syt isoforms play roles
not only in triggering exocytosis, but also in regulating release in
subtle ways. Syts regulate the stability of fusion pores (26–30),
and fusion pore stability in turn is intimately related to release
mode, with the relative frequency of kiss-and-run versus full-
fusion described quantitatively in terms of the kinetic rates of
fusion pore closure and dilation (26). There are many examples of
syts influencing the choice between kiss-and-run and full-fusion
(26, 29, 31–33). Syts are conserved proteins with well established
functions in membrane trafficking and exocytosis. They contain
two C2 domains, and in syt 1, the first isoform to be charac-
terized, each C2 domain binds two or three Ca2+ ions through
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interactions with key aspartate side chains (34). Syts interact
with lipid membranes containing specific phospholipids including
phosphatidylserine and phosphatidylinositol-4,5-biphosphate, as
well as SNARE proteins. These interactions are regulated by Ca2+,
but it remains unclear how binding to these targets enables syts to
serve as Ca2+ sensors in exocytosis (21, 22, 30).
The mouse and human genomes encode 17 syt isoforms (35),
and the functional significance of syt diversity is a subject of
considerable interest (22, 36, 37). Syts vary widely in their Ca2+-
dependent lipid binding, with syts 1, 2, and 3 binding rapidly,
syts 5, 6, 9, and 10 binding at an intermediate rate, and syt 7
binding slowly (38). The isoforms also vary in their activity in
Ca2+-stimulated liposome fusion: Ca2+ concentrations that trig-
ger responses range widely between the isoforms, and many syts
completely fail to confer Ca2+ sensitivity on SNARE-mediated
liposome fusion in vitro (32, 39, 40). Variations in Ca2+ sensitivity
and fusion pore regulation make these proteins ideal candidates
for modifying the release apparatus and tuning responses as Ca2+
concentrations rise and fall in distinct spatiotemporal patterns.
Here, we survey relevant work on syt functions in hormone release,
and where possible draw parallels between syt isoform properties,
Ca2+ signals, and forms of secretion.
SYT FUNCTION IN ENDOCRINE CELLS
Synaptotagmins appear broadly throughout the endocrine system,
with essentially every cell type examined expressing multiple iso-
forms (Table 1). Expression varies between cell types and not all
reports agree. No effort was made here to distinguish between iso-
forms untested versus undetected, and the number of isoforms
found in endocrine cells will grow as reagents are developed and
improved, and as proteomics methods advance. A large body
of work supports the expression of syts 1, 4, 7, and 9 in many
endocrine systems, and it is remarkable that these four molecules
appear in so many different cell types. Syts 1, 4, and 7 are ancient,
conserved proteins distributed widely through metazoan genomes
(35). These isoforms presumably perform fundamental biological
functions, and evidence is accumulating for their roles in a wide
range of endocrine and non-endocrine systems.
SYT 1
Syt 1 is the most widely distributed syt isoform in nervous and
endocrine systems. This low-affinity Ca2+ sensor (32, 39, 41, 42)
generally triggers rapid exocytosis. The very tight temporal cou-
pling between Ca2+ entry and fusion, within milliseconds, has
prompted investigators to use the term “synchronous” to describe
this form of release, particularly in the context of synaptic trans-
mission. An early syt 1 knock-down study suggested that PC12
cells can secrete without syt 1 (43), but subsequent work showed
that this was due to redundancy with another syt isoform of PC12
cells, syt 9 (33, 44). Overexpression of wild type syt 1 in PC12 cells
left the overall time course of secretion unchanged, but overexpres-
sion of either wild type syt 1 or a number of syt 1 mutants altered
fusion pore kinetics (26–28, 30, 45). Overexpressing syt 1 in PC12
cells also produced more kiss-and-run events than syt 7 and 9 (32).
Deletion of the syt 1 gene in mouse selectively abolished the ini-
tial rapid phase of exocytosis in chromaffin cells (33, 46, 47), but
had no deleterious effects on slower Ca2+-triggered release. For a
Table 1 | Syt isoform expression in various endocrine systems.
Cells Syt isoforms Reference
PC12 cells 1, 4, 7, 9 Tucker et al. (55)
1, 9 Lynch and Martin (44), Fukuda
et al. (54)
3 Mizuta et al. (82)
3, 5, 6, 10 Saegusa et al. (83)
8 Monterrat et al. (68)
Chromaffin cells 1, 4, 7, 9 Matsuoka et al. (84)
1, 7 Schonn et al. (47)
1 Voets et al. (46)
Hypothalamus 1–4 Xi et al. (71)
Anterior pituitary 1, 3, 4 Xi et al. (71)
LβT2 1, 4 Hu et al. (85)
AtT20 3 Mizuta et al. (82)
4 Eaton et al. (65)
GH3 3 Mizuta et al. (82)
Posterior pituitary 1, 4 Zhang et al. (63)
Intermediate pituitary
(melanotrophs)
1, 3, 4, 7, 9 Kreft et al. (86)
Pancreatic islets 3, 4, 7 Gao et al. (87)
3 Mizuta et al. (88)
5, 9 Iezzi et al. (89)
7 Gustavsson et al. (51)
Pancreatic β-cells 3 Brown et al. (90)
4 Gut et al. (67)
7 Gustavsson et al. (50)
β-Cell linesa 1–4, 7, 8 Gao et al. (87)
1, 2 Lang et al. (91)
3 Gut et al. (67), Mizuta et al.
(82), Mizuta et al. (88)
4, 7, 11, 13 Andersson et al. (69)
5, 9 Iezzi et al. (89)
8 Monterrat et al. (68)
Pancreatic α cells 7 Gustavsson et al. (51)
In most cases the localization and expression was based on immunocytochem-
istry (see text).
aβ-Cell lines include RINm5F, INS1, MN6, HT-T15, TC6-F7.
given concentration of Ca2+, exocytosis was much slower in chro-
maffin cells lacking syt 1 than in control cells (46). Mutation of a
residue that reduces Ca2+ binding slowed exocytosis in chromaffin
cells (48). In PC12 cells syt 1 sorted preferentially to smaller DCVs
(32), raising the interesting possibility that hormones packaged
in smaller vesicles will be released more rapidly than hormones
packaged in larger vesicles.
SYT 7
In contrast to syt 1, syt 7 acts as a high affinity Ca2+ sensor (32,
39, 49). Syt 7 is more abundant on larger DCVs in PC12 cells (32).
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Syt 7 overexpression in PC12 cells prolonged fusion pore life-
times more than syt 1 overexpression (30), and favored full-fusion
(32). Syt 7 knock-down in zebra fish reduced delayed synaptic
release, indicating it is a slow Ca2+ sensor (49). Syt 7 deletion
in chromaffin cells reduced Ca2+-triggered release by 50%, also
selectively impairing the slow phase of exocytosis, and deletion
of both syt 1 and 7 nearly abolished Ca2+-triggered exocytosis.
Thus, in chromaffin cells syt 1 and 7 are the primary Ca2+ sen-
sors for the fast and slow kinetic phases of exocytosis, respectively
(47). Syt 7 gene ablation also reduced Ca2+-triggered exocytosis
of insulin secretion from pancreatic β-cells and of glucagon secre-
tion from pancreatic α-cells (50, 51). It is intriguing that syt 7 also
functions in insulin responsive cells (fat and muscle), promoting
glucose uptake through Ca2+-stimulated translocation of type-4
glucose transporter to the plasma membrane (52). In syt 7 knock-
out α cells, ω-conotoxin further inhibited glucagon secretion to
baseline levels, revealing the presence of an N-type Ca2+ channel-
dependent component of residual glucagon secretion triggered by
another protein (51).
SYT 9
Syt 9 is closely related to syt 1 but exhibits intermediate Ca2+ sen-
sitivity in fusion assays (32, 39). This protein has also been referred
to as syt 5 (35, 53); here syt 9 refers to a 386 amino acid isoform. It
is abundant on DCVs of PC12 cells (32, 54, 55), and overexpress-
ing it produces fusion pore lifetimes intermediate between those
seen with syt 1 and 7 (30). Down-regulating syt 9 alone produced
a small, insignificant reduction of fusion rate in PC12 cells, but
as noted above, because of the redundancy of syt 1 and 9 as Ca2+
sensors, both must be down-regulated to reduce secretion (33, 44).
Silencing of syt 9 strongly inhibited insulin release from islet β-
cells and INS-1E cells (56). However, mice with a pancreas-specific
knock-out of syt 9 had normal glucose homeostasis and showed
no changes in other insulin-dependent functions (57).
CA2+ NON-BINDERS
Slightly more than half of the mammalian syts have non-acidic
amino acids at some of the positions engaged in Ca2+ binding
(35), and these isoforms fail to act as Ca2+ sensors in liposome
fusion assays (40). The best characterized of these, syt 4, harbors
an evolutionarily conserved serine-for-aspartate substitution at a
Ca2+ ligand in the C2A domain (58). Syt 4 is widely expressed
in endocrine cells and its expression rises and falls depending on
electrical activity (59) and reproductive state (60). Syt 4 nega-
tively regulates both release and Ca2+-dependent liposome fusion
(28, 32, 40) and does not bind Ca2+ (61). Syt 4 overexpression
reduced exocytosis in PC12 cells (28, 32, 62). Although syt 4 over-
expression in PC12 cells shortened the lifetimes of fusion pores
capable of dilating to full-fusion (28), another form of release was
enhanced in which very small fusion pores could open exclusively
as kiss-and-run events with exceptionally long lifetimes. Many but
not all of the effects of syt 4 overexpression were mimicked by syt
1 harboring the serine-for-alanine Ca2+ ligand replacement seen
in syt 4 (29). Syt 4 overexpression also favored kiss-and-run in
MIN6 β-cells (31). Ablation of the syt 4 gene altered exocytosis
and fusion pore properties in posterior pituitary nerve terminals.
These results suggested that syt 4 reduced exocytosis in response
to modest Ca2+ rises but enhanced exocytosis in response to large
Ca2+ rises (63). Syt 4 also contributes to the maturation of DCVs
(64, 65), and altering syt 4 levels changes DCV size (62, 63, 66).
The Ca2+ non-binding isoforms syt 4, 8, and 13 have been
detected in insulin-secreting cells (67–69). Silencing syt 4 and 13
reduced glucose stimulated insulin secretion in INS1 cells (69).
Glucose stimulated expression of the syt 8 gene in human islets
and syt 8 knock-down impaired both basal and evoked insulin
release (70). Since syt 8 fails to stimulate liposome fusion in a
Ca2+-dependent manner (40) the precise role of syt 8 in insulin
secretion remains unclear. One intriguing possibility is that syt
8 increases the relative proportion of full-fusion events so that
fusion pores can grow large enough to allow insulin to escape. It is
likely that the Ca2+ non-binders interact with other components
of the release machinery in ways that remain to be elucidated.
These interactions could allow syts to regulate release in ways that
cannot as yet be explained in terms of their biochemical properties.
Reports vary regarding the expression of other syt isoforms in
endocrine cells (Table 1) and little is known about their localiza-
tion and functions in hormone release. Syt 2 has been reported in
the hypothalamus (71) but is absent from endocrine cells, and its
primary function is likely to be as a synaptic Ca2+ sensor (72, 73).
SPECIFICITY OF CA2+ SIGNALING
The differences in performance of syts as Ca2+ sensors gives a spe-
cial significance to the spatiotemporal character of Ca2+ signals in
different cell types and with different forms of stimuli. Ca2+ can
enter cells through a variety of routes so that the dynamics and spa-
tial extent of changes in cytosolic Ca2+ can vary enormously. This
creates a scenario in which differences in Ca2+ sensing properties
can have a major impact on responses (74). Intracellular Ca2+ rises
and falls as Ca2+ enters through Ca2+ channels, diffuses away from
these sources into the cytoplasm, binds Ca2+ binding proteins, and
is sequestered into stores or pumped out of the cytoplasm (75–77).
The opening of one voltage gated Ca2+ channel allows approxi-
mately 103 ions to enter per msec. This localized flux sets up a
steep gradient to create a domain of high local Ca2+ concentra-
tion. In the immediate vicinity of the channel mouth (within tens
of nanometer) Ca2+ can rise to >100µM, which is substantially
higher than the average bulk cytoplasmic level, even under condi-
tions of intense stimulation (75, 78). These Ca2+ domains around
a Ca2+ channel can form and collapse rapidly (within a few ms)
so that the activation of a Ca2+ sensor will depend critically on
the kinetics of Ca2+ association and dissociation. A low-affinity
sensor can detect this high local Ca2+ as long as it binds with rapid
kinetics. A high affinity Ca2+ sensor may fail to respond if it binds
too slowly. Syt 1 has properties suited for responding to transient
domains with high Ca2+. Syt 7 has properties suited for responding
to modest but prolonged rises in bulk Ca2+ concentration (38).
The idea of localized Ca2+ signals leads to two types of Ca2+
concentration profile illustrated in Figure 1. When an endocrine
cell fires at a moderate rate, Ca2+ domains form and collapse
around a few open Ca2+ channels as shown in Figure 1A. The
resulting brief period of high Ca2+ concentration will only affect
vesicles near the open channels, and will preferentially activate
syt 1 over slower isoforms. Basal firing rates corresponding to
the resting state of an animal (feed and breed) have been shown
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FIGURE 1 | Ca2+ domains and release mechanisms. (A)Weak
stimulation opens Ca2+ channels less frequently. One isolated channel
can open and as Ca2+ flows a domain of high Ca2+ concentration will
form around the channel mouth. This will lead to a highly localized Ca2+
signal that will persist for milliseconds. A Ca2+ sensor such as syt 1,
with its rapid kinetics and low affinity, can be activated by a Ca2+ signal
of this form. (B) Strong stimulation opens many Ca2+ channels to raise
bulk Ca2+. Bulk Ca2+ can also rise as a result of Ca2+ release from
internal stores. After the stimulus ends the Ca2+ gradients around
individual vesicles will collapse as Ca2+ diffuses through the cytoplasm
away from the membrane. This will lead to a more uniform, moderate
concentration that can persist for seconds. A Ca2+ sensor such as syt 7,
with its slow kinetics and high affinity, can be activated by a Ca2+ signal
of this form.
to trigger norepinephrine release from chromaffin cells without
triggering chromogranin release (11). This implicates exocytosis
by kiss-and-run, which is preferentially triggered by syt 1 (32).
By contrast, with vigorous electrical activity during stress (fight
and flight) the bulk Ca2+ concentration will rise to moderate lev-
els (well under 50µM) for longer times on the order of seconds
(Figure 1B). These signals will activate slow, low-affinity Ca2+
sensors such as syt 7. This form of [Ca2+] signal has been shown
to trigger full-fusion (79), with release of both norepinephrine and
chromogranin (11). This can be explained by the tendency of syt 7
to trigger full-fusion preferentially (32). Different spatiotemporal
patterns of cytosolic Ca2+ can thus target different syt isoforms
to modulate fusion kinetics. Furthermore, because syt isoforms
favor different modes of exocytosis, by selectively promoting kiss-
and-run or full-fusion, Ca2+ signals that activate different syts
will determine the relative release of small and large molecules.
The sorting of syts to different sized vesicles may also serve as a
mechanism for allowing different Ca2+ signals to select different
substances for release if content is also found to vary with vesicle
size (32).
CONCLUSION
Studies of how different syt isoforms influence the kinetics of exo-
cytosis are starting to resolve functionally relevant distinctions in
the mechanisms by which Ca2+ regulates exocytosis. More stud-
ies like these will expand our understanding of the diversity of
endocrine release mechanisms, but rigorous assessments of syt
isoform function in cells face a number of challenges. (1) It is
important to address the expression of multiple isoforms, either
by ablating endogenous proteins or varying each isoform indi-
vidually with careful assessment of protein levels. Overexpression
of proteins can result in high protein concentrations, possibly
leading to mis-targeting and artificial functions. (2) Experiments
need to address the different Ca2+ sensitivities of syt isoforms.
This requires measurement and control of Ca2+ concentration.
(3) Biophysical techniques for measuring exocytosis are very sen-
sitive but often measure surrogates of release and detect events
on different time scales. Amperometry measures release and can
detect rapid processes but its greatest sensitivity is realized with
biogenic amines, and is not nearly as powerful in the measure-
ment of peptides. Furthermore, after content expulsion the closure
of a fusion pore can no longer be detected, and the mode of
release as kiss-and-run or full-fusion can no longer be ascer-
tained. Capacitance measures membrane area, and single-vesicle
capacitance steps provide strong evidence for kiss-and-run. Total
internal reflectance microscopy of fluorescent tracers follows the
fate of the vesicle content or membrane (80). Like capacitance
recording, this method can reveal kiss-and-run but its time reso-
lution is poor. Furthermore, the fate of fluorescent cargo can vary
with the design of the fusion construct, raising concerns about
experimental artifacts (81). Amperometry, capacitance, and total
internal reflectance microscopy are very powerful techniques but
they do not always agree and these differences can complicate
interpretations and comparisons (62).
Given the functional versatility within the syt protein family, the
studies to date probably have only scratched the surface in address-
ing the roles of syt isoforms in the complex and varied forms of
hormone release. By selecting among the different syt isoforms
and regulating their expression, and by sorting to different vesicles
containing different hormones, cells can regulate the response to
diverse forms of Ca2+ signals. The syt isoforms present on a vesicle
will determine what form of Ca2+ signal will trigger fusion, how
different Ca2+ signals direct the choice between kiss-and-run and
full-fusion, and what proportion of small and large molecules are
released.
ACKNOWLEDGMENTS
This research was supported by NIH grants NS044057 and
NS072905. We thank Drs. Xuelin Lou and Edwin Chapman for
helpful discussions and comments.
Frontiers in Endocrinology | Neuroendocrine Science September 2013 | Volume 4 | Article 124 | 4
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Moghadam and Jackson Synaptotagmin diversity in neuroendocrine secretion
REFERENCES
1. De Camilli P, Jahn R. Pathways to
regulated exocytosis in neurons.
Annu Rev Physiol (1990) 52:625–45.
doi:10.1146/annurev.ph.52.030190.
003205
2. Walch-Solimena C, Takei K, Marek
KL, Midyett K, Südhof TC, De
Camilli P, et al. Synaptotag-
min: a membrane constituent of
neuropeptide-containing large
dense-core vesicles. J Neurosci
(1993) 13:3895–903.
3. Brunner Y, Coute Y, Iezzi M, Foti
M, Fukuda M, Hochstrasser DF, et
al. Proteomics analysis of insulin
secretory granules. Mol Cell Pro-
teomics (2007) 6:1007–17. doi:10.
1074/mcp.M600443-MCP200
4. Wegrzyn JL, Bark SJ, Funkelstein L,
Mosier C,Yap A, Kazemi-Esfarjani P,
et al. Proteomics of dense core secre-
tory vesicles reveal distinct pro-
tein categories for secretion of neu-
roeffectors for cell-cell commu-
nication. J Proteome Res (2010)
9:5002–24. doi:10.1021/pr1003104
5. Sudhof TC, Rothman JE. Mem-
brane fusion: grappling with
SNARE and SM proteins.
Science (2009) 323:474–7.
doi:10.1126/science.1161748
6. Jahn R, Scheller RH. SNAREs –
engines for membrane fusion. Nat
Rev Mol Cell Biol (2006) 7:631–43.
doi:10.1038/nrm2002
7. Jahn R, Fasshauer D. Mol-
ecular machines governing
exocytosis of synaptic vesi-
cles. Nature (2012) 490:201–7.
doi:10.1038/nature11320
8. Martin TF. Tuning exocytosis
for speed: fast and slow modes.
Biochim Biophys Acta (2003)
1641:157–65. doi:10.1016/S0167-
4889(03)00093-4
9. Winkler H, Westhead E. The
molecular organization of adrenal
chromaffin granules. Neuroscience
(1980) 5:1803–23. doi:10.1016/
0306-4522(80)90031-7
10. Hokfelt T, Broberger C, Xu ZQ,
Sergeyev V, Ubink R, Diez M.
Neuropeptides – an overview. Neu-
ropharmacology (2000) 39:1337–56.
doi:10.1016/S0028-3908(00)
00010-1
11. Fulop T, Radabaugh S, Smith
C. Activity-dependent differen-
tial transmitter release in mouse
adrenal chromaffin cells. J Neurosci
(2005) 25:7324–32. doi:10.1523/
JNEUROSCI.2042-05.2005
12. MacDonald PE, Braun M, Gal-
vanovskis J, Rorsman P. Release
of small transmitters through
kiss-and-run fusion pores
in rat pancreatic beta cells.
Cell Metab (2006) 4:283–90.
doi:10.1016/j.cmet.2006.08.011
13. Whim MD. Near simultaneous
release of classical and peptide
cotransmitters from chromaffin
cells. J Neurosci (2006) 26:6637–42.
doi:10.1523/JNEUROSCI.5100-05.
2006
14. Perello M, Stuart R, Nillni EA.
Prothyrotropin-releasing hor-
mone targets its processing
products to different vesicles
of the secretory pathway. J Biol
Chem (2008) 283:19936–47.
doi:10.1074/jbc.M800732200
15. Sossin WS, Scheller RH. Biosynthe-
sis and sorting of neuropeptides.
Curr Opin Neurobiol (1991)
1:79–83. doi:10.1016/0959-
4388(91)90013-W
16. Alvarez de Toledo G, Fernández-
Chacón R, Fernández JM. Release
of secretory products during tran-
sient vesicle fusion. Nature (1993)
363:554–8. doi:10.1038/363554a0
17. Fernandez JM, Neher E, Gom-
perts BD. Capacitance measure-
ments reveal stepwise fusion
events in degranulating mast
cells. Nature (1984) 312:453–5.
doi:10.1038/312453a0
18. Klyachko VA, Jackson MB.
Capacitance steps and fusion
pores of small and large-dense-
core vesicles in nerve termi-
nals. Nature (2002) 418:89–92.
doi:10.1038/nature00852
19. Neher E, Marty A. Discrete changes
of cell membrane capacitance
observed under conditions of
enhanced secretion in bovine
adrenal chromaffin cells. Proc Natl
Acad Sci U S A (1982) 79:6712–6.
doi:10.1073/pnas.79.21.6712
20. Kim T, Gondré-Lewis MC,
Arnaoutova I, Loh YP. Dense-core
secretory granule biogenesis. Physi-
ology (Bethesda) (2006) 21:124–33.
doi:10.1152/physiol.00043.2005
21. Augustine GJ. How does calcium
trigger neurotransmitter release?
Curr Opin Neurobiol (2001)
11:320–6. doi:10.1016/S0959-
4388(00)00214-2
22. Chapman ER. How does synap-
totagmin trigger neurotransmitter
release? Annu Rev Biochem (2008)
77:615–41. doi:10.1146/annurev.
biochem.77.062005.101135
23. Koh TW, Bellen HJ. Synaptotag-
min I, a Ca2+ sensor for neu-
rotransmitter release. Trends Neu-
rosci (2003) 26:413–22. doi:10.
1016/S0166-2236(03)00195-4
24. Ales E, Tabares L, Poyato JM, Valero
V, Lindau M, Alvarez de Toledo
G. High calcium concentrations
shift the mode of exocytosis to the
kiss-and-run mechanism. Nat Cell
Biol (1999) 1:40–4. doi:10.1038/
9012
25. Fernandez-Chacon R, Alvarez de
Toledo G. Cytosolic calcium facil-
itates release of secretory products
after exocytotic vesicle fusion. FEBS
Lett (1995) 363:221–5. doi:10.1016/
0014-5793(95)00319-5
26. Wang CT, Bai J, Chang PY, Chapman
ER, Jackson MB. Synaptotagmin-
Ca2+ triggers two sequential steps
in regulated exocytosis in rat PC12
cells: fusion pore opening and
fusion pore dilation. J Physiol
(2006) 570:295–307.
27. Bai J, Wang CT, Richards DA,
Jackson MB, Chapman ER. Fusion
pore dynamics are regulated by
synaptotagmin*t-SNARE interac-
tions. Neuron (2004) 41:929–42.
doi:10.1016/S0896-6273(04)
00117-5
28. Wang CT, Grishanin R, Earles CA,
Chang PY, Martin TF, Chapman
ER, et al. Synaptotagmin modula-
tion of fusion pore kinetics in regu-
lated exocytosis of dense-core vesi-
cles. Science (2001) 294:1111–5. doi:
10.1126/science.1064002
29. Wang CT, Lu JC, Bai J, Chang
PY, Martin TF, Chapman ER, et
al. Different domains of synap-
totagmin control the choice
between kiss-and-run and full
fusion. Nature (2003) 424:943–7.
doi:10.1038/nature01857
30. Zhang Z, Hui E, Chapman ER, Jack-
son MB. Regulation of exocytosis
and fusion pores by synaptotagmin-
effector interactions. Mol Biol Cell
(2010) 21:2821–31. doi:10.1091/
mbc.E10-04-0285
31. Tsuboi T, Rutter GA. Multiple
forms of “kiss-and-run” exocyto-
sis revealed by evanescent wave
microscopy. Curr Biol (2003)
13:563–7. doi:10.1016/S0960-
9822(03)00176-3
32. Zhang Z, Wu Y, Wang Z, Dunning
FM, Rehfuss J, Ramanan D, et al.
Release mode of large and small
dense-core vesicles specified by dif-
ferent synaptotagmin isoforms in
PC12 cells. Mol Biol Cell (2011)
22:2324–36. doi:10.1091/mbc.E11-
02-0159
33. Zhu D, Zhou W, Liang T, Yang F,
Zhang RY, Wu ZX, et al. Synaptotag-
min I and IX function redundantly
in controlling fusion pore of
large dense core vesicles. Biochem
Biophys Res Commun (2007)
361:922–7. doi:10.1016/j.bbrc.
2007.07.083
34. Ubach J, Zhang X, Shao X, Sudhof
TC, Rizo J. Ca2+ binding to synap-
totagmin: how many Ca2+ ions
bind to the tip of a C2-domain?
EMBO J (1998) 17:3921–30. doi:10.
1093/emboj/17.14.3921
35. Craxton M. A manual collection
of Syt, Esyt, Rph3a, Rph3al, Doc2,
and Dblc2 genes from 46 metazoan
genomes – an open access resource
for neuroscience and evolution-
ary biology. BMC Genomics (2010)
11:37. doi:10.1186/1471-2164-11-
37
36. Marqueze B, Berton F, Seagar M.
Synaptotagmins in membrane
traffic: which vesicles do the
tagmins tag? Biochimie (2000)
82:409–20. doi:10.1016/S0300-
9084(00)00220-0
37. Sudhof TC. Synaptotag-
mins: why so many? J Biol
Chem (2002) 277:7629–32.
doi:10.1074/jbc.R100052200
38. Hui E, Bai J, Wang P, Sugimori M,
Llinas RR, Chapman ER. Three dis-
tinct kinetic groupings of the synap-
totagmin family: candidate sen-
sors for rapid and delayed exo-
cytosis. Proc Natl Acad Sci U S
A (2005) 102:5210–4. doi:10.1073/
pnas.0500941102
39. Bhalla A, Tucker WC, Chapman
ER. Synaptotagmin isoforms cou-
ple distinct ranges of Ca2+, Ba2+,
and Sr2+ concentration to SNARE-
mediated membrane fusion. Mol
Biol Cell (2005) 16:4755–64. doi:10.
1091/mbc.E05-04-0277
40. Bhalla A, Chicka MC, Chapman
ER. Analysis of the synaptotag-
min family during reconstituted
membrane fusion. Uncovering a
class of inhibitory isoforms. J Biol
Chem (2008) 283:21799–807. doi:
10.1074/jbc.M709628200
41. Li C, Ullrich B, Zhang JZ, Anderson
RG, Brose N, Südhof TC. Ca(2+)-
dependent and -independent
activities of neural and non-neural
synaptotagmins. Nature (1995)
375:594–9. doi:10.1038/375594a0
42. Sugita S, Shin OH, Han W,
Lao Y, Sudhof TC. Synaptotag-
mins form a hierarchy of exocy-
totic Ca(2+) sensors with distinct
Ca(2+) affinities. EMBO J (2002)
21:270–80. doi:10.1093/emboj/21.
3.270
43. Shoji-Kasai Y, Yoshida A, Sato K,
Hoshino T, Ogura A, Kondo S, et
al. Neurotransmitter release from
synaptotagmin-deficient clonal
variants of PC12 cells. Science
(1992) 256:1821–3.
44. Lynch KL, Martin TF. Synaptotag-
mins I and IX function redun-
dantly in regulated exocytosis but
not endocytosis in PC12 cells. J Cell
Sci (2007) 120:617–27. doi:10.1242/
jcs.03375
www.frontiersin.org September 2013 | Volume 4 | Article 124 | 5
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Moghadam and Jackson Synaptotagmin diversity in neuroendocrine secretion
45. Lynch KL, Gerona RR, Kielar DM,
Martens S, McMahon HT, Mar-
tin TF. Synaptotagmin-1 utilizes
membrane bending and SNARE
binding to drive fusion pore
expansion. Mol Biol Cell (2008)
19:5093–103. doi:10.1091/mbc.
E08-03-0235
46. Voets T, Moser T, Lund PE, Chow
RH, Geppert M, Sudhof TC, et
al. Intracellular calcium dependence
of large dense-core vesicle exocy-
tosis in the absence of synapto-
tagmin I. Proc Natl Acad Sci U S
A (2001) 98:11680–5. doi:10.1073/
pnas.201398798
47. Schonn JS, Maximov A, Lao
Y, Sudhof TC, Sorensen JB.
Synaptotagmin-1 and -7 are
functionally overlapping Ca2+
sensors for exocytosis in adrenal
chromaffin cells. Proc Natl Acad
Sci U S A (2008) 105:3998–4003.
doi:10.1073/pnas.0712373105
48. Sorensen JB, Fernandez-Chacon R,
Sudhof TC, Neher E. Examin-
ing synaptotagmin 1 function in
dense core vesicle exocytosis under
direct control of Ca2+. J Gen Phys-
iol (2003) 122:265–76. doi:10.1085/
jgp.200308855
49. Wen H, Linhoff MW, McGinley MJ,
Li GL, Corson GM, Mandel G, et al.
Distinct roles for two synaptotag-
min isoforms in synchronous and
asynchronous transmitter release
at zebrafish neuromuscular junc-
tion. Proc Natl Acad Sci U S A
(2010) 107:13906–11. doi:10.1073/
pnas.1008598107
50. Gustavsson N, Lao Y, Maximov
A, Chuang JC, Kostromina E,
Repa JJ, et al. Impaired insulin
secretion and glucose intolerance
in synaptotagmin-7 null mutant
mice. Proc Natl Acad Sci U S
A (2008) 105:3992–7. doi:10.1073/
pnas.0711700105
51. Gustavsson N, Wei SH, Hoang DN,
Lao Y, Zhang Q, Radda GK, et al.
Synaptotagmin-7 is a principal Ca2+
sensor for Ca2+-induced glucagon
exocytosis in pancreas. J Physiol
(2009) 587:1169–78. doi:10.1113/
jphysiol.2008.168005
52. Li Y, Wang P, Xu J, Gorelick
F, Yamazaki H, Andrews N, et
al. Regulation of insulin secre-
tion and GLUT4 trafficking by
the calcium sensor synaptotagmin
VII. Biochem Biophys Res Commun
(2007) 362:658–64. doi:10.1016/j.
bbrc.2007.08.023
53. Fukuda M, Sagi-Eisenberg R.
Confusion in the nomenclature
of synaptotagmins V and IX.
Calcium Bind Proteins (2008)
3:1–4.
54. Fukuda M, Kowalchyk JA, Zhang
X, Martin TF, Mikoshiba K.
Synaptotagmin IX regulates Ca2+-
dependent secretion in PC12 cells.
J Biol Chem (2002) 277:4601–4.
doi:10.1074/jbc.C100588200
55. Tucker WC, Edwardson JM, Bai
J, Kim HJ, Martin TF, Chapman
ER. Identification of synaptotag-
min effectors via acute inhibition of
secretion from cracked PC12 cells.
J Cell Biol (2003) 162:199–209. doi:
10.1083/jcb.200302060
56. Iezzi M, Eliasson L, Fukuda
M, Wollheim CB. Adenovirus-
mediated silencing of synap-
totagmin 9 inhibits Ca2+-
dependent insulin secretion in
islets. FEBS Lett (2005) 579:5241–6.
doi:10.1016/j.febslet.2005.08.047
57. Gustavsson N, Wang X, Wang
Y, Seah T, Xu J, Radda GK,
et al. Neuronal calcium sensor
synaptotagmin-9 is not involved in
the regulation of glucose home-
ostasis or insulin secretion. PLoS
One (2010) 5:e15414. doi:10.1371/
journal.pone.0015414
58. von Poser C, Ichtchenko K, Shao
X, Rizo J, Sudhof TC. The evo-
lutionary pressure to inactivate. A
subclass of synaptotagmins with an
amino acid substitution that abol-
ishes Ca2+ binding. J Biol Chem
(1997) 272:14314–9. doi:10.1074/
jbc.272.22.14314
59. Vician L, Lim IK, Ferguson G,
Tocco G, Baudry M, Herschman
HR. Synaptotagmin IV is an imme-
diate early gene induced by depo-
larization in PC12 cells and in
brain. Proc Natl Acad Sci U S
A (1995) 92:2164–8. doi:10.1073/
pnas.92.6.2164
60. Poopatanapong A, Teramitsu I,
Byun JS, Vician LJ, Herschman HR,
White SA. Singing, but not seizure,
induces synaptotagmin IV in zebra
finch song circuit nuclei. J Neu-
robiol (2006) 66:1613–29. doi:10.
1002/neu.20329
61. Dai H, Shin OH, Machius M, Tom-
chick DR, Sudhof TC, Rizo J. Struc-
tural basis for the evolutionary inac-
tivation of Ca2+ binding to synap-
totagmin 4. Nat Struct Mol Biol
(2004) 11:844–9. doi:10.1038/
nsmb817
62. Zhang Z, Zhang Z, Jackson MB.
Synaptotagmin IV modulation of
vesicle size and fusion pores in
PC12 cells. Biophys J (2010)
98:968–78. doi:10.1016/j.bpj.2009.
11.024
63. Zhang Z, Bhalla A, Dean C, Chap-
man ER, Jackson MB. Synaptotag-
min IV: a multifunctional regulator
of peptidergic nerve terminals. Nat
Neurosci (2009) 12:163–71. doi:10.
1038/nn.2252
64. Ahras M, Otto GP, Tooze SA.
Synaptotagmin IV is necessary for
the maturation of secretory gran-
ules in PC12 cells. J Cell Biol
(2006) 173(2):242–51. doi:10.1083/
jcb.200506163
65. Eaton BA, Haugwitz M, Lau D,
Moore HP. Biogenesis of regu-
lated exocytotic carriers in neu-
roendocrine cells. J Neurosci (2000)
20:7334–44.
66. Wang P, Wang CT, Bai J, Jackson
MB, Chapman ER. Mutations in
the effector binding loops in the
C2A and C2B domains of synap-
totagmin I disrupt exocytosis in a
nonadditive manner. J Biol Chem
(2003) 278:47030–7. doi:10.1074/
jbc.M306728200
67. Gut A, Kiraly CE, Fukuda M,
Mikoshiba K, Wollheim CB, Lang
J. Expression and localisation
of synaptotagmin isoforms in
endocrine beta-cells: their function
in insulin exocytosis. J Cell Sci
(2001) 114:1709–16.
68. Monterrat C, Boal F, Grise F,
Hemar A, Lang J. Synaptotag-
min 8 is expressed both as a
calcium-insensitive soluble and
membrane protein in neurons,
neuroendocrine and endocrine
cells. Biochim Biophys Acta (2006)
1763:73–81. doi:10.1016/j.bbamcr.
2005.11.008
69. Andersson SA, Olsson AH, Esguerra
JL, Heimann E, Ladenvall C, Edlund
A, et al. Reduced insulin secretion
correlates with decreased expression
of exocytotic genes in pancreatic
islets from patients with type 2 dia-
betes. Mol Cell Endocrinol (2012)
364:36–45. doi:10.1016/j.mce.2012.
08.009
70. Xu Z, Wei G, Chepelev I, Zhao K,
Felsenfeld G. Mapping of INS pro-
moter interactions reveals its role
in long-range regulation of SYT8
transcription. Nat Struct Mol Biol
(2011) 18:372–8. doi:10.1038/
nsmb.1993
71. Xi D, Chin H, Gainer H. Analy-
sis of synaptotagmin I-IV mes-
senger RNA expression and devel-
opmental regulation in the rat
hypothalamus and pituitary. Neu-
roscience (1999) 88:425–35. doi:10.
1016/S0306-4522(98)00234-6
72. Kochubey O, Schneggenburger
R. Synaptotagmin increases
the dynamic range of synapses
by driving Ca(2)+-evoked
release and by clamping a near-
linear remaining Ca(2)+ sen-
sor. Neuron (2011) 69:736–48.
doi:10.1016/j.neuron.2011.01.013
73. Sun J, Pang ZP, Qin D, Fahim
AT, Adachi R, Südhof TC. A dual-
Ca2+-sensor model for neurotrans-
mitter release in a central synapse.
Nature (2007) 450:676–82. doi:10.
1038/nature06308
74. Kasai H. Comparative biology
of Ca2+-dependent exocytosis:
implications of kinetic diversity for
secretory function. Trends Neurosci
(1999) 22:88–93. doi:10.1016/
S0166-2236(98)01293-4
75. Neher E. Vesicle pools and Ca2+
microdomains: new tools for
understanding their roles in neuro-
transmitter release. Neuron (1998)
20:389–99. doi:10.1016/S0896-
6273(00)80983-6
76. Neher E. Usefulness and limita-
tions of linear approximations
to the understanding of Ca++
signals. Cell Calcium (1998)
24:345–57. doi:10.1016/S0143-
4160(98)90058-6
77. Augustine GJ, Santamaria F, Tanaka
K. Local calcium signaling in neu-
rons. Neuron (2003) 40:331–46. doi:
10.1016/S0896-6273(03)00639-1
78. Yamada WM, Zucker RS. Time
course of transmitter release cal-
culated from simulations of a
calcium diffusion model. Biophys
J (1992) 61:671–82. doi:10.1016/
S0006-3495(92)81872-6
79. Elhamdani A, Azizi F, Artalejo CR.
Double patch clamp reveals that
transient fusion (kiss-and-run) is a
major mechanism of secretion in
calf adrenal chromaffin cells: high
calcium shifts the mechanism from
kiss-and-run to complete fusion. J
Neurosci (2006) 26:3030–6. doi:10.
1523/JNEUROSCI.5275-05.2006
80. Michael DJ, Cai H, Xiong W,
Ouyang J, Chow RH. Mechanisms
of peptide hormone secretion.
Trends Endocrinol Metab (2006)
17:408–15. doi:10.1016/j.tem.2006.
10.011
81. Michael DJ, Geng X, Cawley NX,
Loh YP, Rhodes CJ, Drain P, et
al. Fluorescent cargo proteins in
pancreatic beta-cells: design deter-
mines secretion kinetics at exocy-
tosis. Biophys J (2004) 87:L03–5.
doi:10.1529/biophysj.104.052175
82. Mizuta M, Inagaki N, Nemoto
Y, Matsukura S, Takahashi M,
Seino S. Synaptotagmin III is a
novel isoform of rat synaptotag-
min expressed in endocrine and
neuronal cells. J Biol Chem (1994)
269:11675–8.
83. Saegusa C, Fukuda M, Mikoshiba
K. Synaptotagmin V is tar-
geted to dense-core vesicles that
undergo calcium-dependent
exocytosis in PC12 cells. J Biol
Frontiers in Endocrinology | Neuroendocrine Science September 2013 | Volume 4 | Article 124 | 6
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Moghadam and Jackson Synaptotagmin diversity in neuroendocrine secretion
Chem (2002) 277:24499–505.
doi:10.1074/jbc.M202767200
84. Matsuoka H, Harada K, Naka-
mura J, Fukuda M, Inoue M.
Differential distribution of
synaptotagmin-1, -4, -7, and -
9 in rat adrenal chromaffin cells.
Cell Tissue Res (2011) 344:41–50.
doi:10.1007/s00441-011-1131-8
85. Hu ZT, Chen MR, Ping Z, Dong
YM, Zhang RY, Xu T, et al. Synap-
totagmin IV regulates dense core
vesicle (DCV) release in LbetaT2
cells. Biochem Biophys Res Commun
(2008) 371:781–6. doi:10.1016/j.
bbrc.2008.04.174
86. Kreft M, Kuster V, Grilc S, Rup-
nik M, Milisav I, Zorec R. Synap-
totagmin I increases the probabil-
ity of vesicle fusion at low [Ca2+]
in pituitary cells. Am J Physiol Cell
Physiol (2003) 284:C547–54. doi:10.
1152/ajpcell.00333.2002
87. Gao Z, Reavey-Cantwell J,
Young RA, Jegier P, Wolf
BA. Synaptotagmin III/VII
isoforms mediate Ca2+-
induced insulin secretion in
pancreatic islet beta-cells. J Biol
Chem (2000) 275:36079–85.
doi:10.1074/jbc.M004284200
88. Mizuta M, Kurose T, Miki T, Shoji-
Kasai Y, Takahashi M, Seino S, et al.
Localization and functional role of
synaptotagmin III in insulin secre-
tory vesicles in pancreatic beta-cells.
Diabetes (1997) 46:2002–6. doi:10.
2337/diabetes.46.12.2002
89. Iezzi M, Kouri G, Fukuda M,
Wollheim CB. Synaptotagmin V
and IX isoforms control Ca2+-
dependent insulin exocytosis. J Cell
Sci (2004) 117:3119–27. doi:10.
1242/jcs.01179
90. Brown H, Meister B, Deeney J,
Corkey BE, Yang SN, Larsson O,
et al. Synaptotagmin III isoform
is compartmentalized in pancreatic
beta-cells and has a functional
role in exocytosis. Diabetes (2000)
49:383–91. doi:10.2337/diabetes.49.
3.383
91. Lang J, Fukuda M, Zhang H,
Mikoshiba K, Wollheim CB. The
first C2 domain of synaptotagmin
is required for exocytosis of insulin
from pancreatic beta-cells: action
of synaptotagmin at low micro-
molar calcium. EMBO J (1997)
16:5837–46. doi:10.1093/emboj/16.
19.5837
Conflict of Interest Statement: The
authors declare that the research was
conducted in the absence of any com-
mercial or financial relationships that
could be construed as a potential con-
flict of interest.
Received: 23 June 2013; accepted: 31
August 2013; published online: 18 Sep-
tember 2013.
Citation: Moghadam PK and Jack-
son MB (2013) The functional signifi-
cance of synaptotagmin diversity in neu-
roendocrine secretion. Front. Endocrinol.
4:124. doi: 10.3389/fendo.2013.00124
This article was submitted to Neuroen-
docrine Science, a section of the journal
Frontiers in Endocrinology.
Copyright © 2013 Moghadam and Jack-
son. This is an open-access article distrib-
uted under the terms of the Creative Com-
mons Attribution License (CC BY). The
use, distribution or reproduction in other
forums is permitted, provided the origi-
nal author(s) or licensor are credited and
that the original publication in this jour-
nal is cited, in accordance with accepted
academic practice. No use, distribution or
reproduction is permitted which does not
comply with these terms.
www.frontiersin.org September 2013 | Volume 4 | Article 124 | 7
